Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 October 2024
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-14-17-october-2024
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 September-3 October 2024
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-30-september-3-october-2024
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2024
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-16-19-september-2024
New European regulations on substances of human origin (SoHO)
https://ansm.sante.fr/actualites/nouvelle-reglementation-europeenne-sur-les-substances-dorigine-humaine-soho
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 July 2024
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-8-11-july-2024
Compassionate access: update of e-saturne, the authorization request application for professionals
https://ansm.sante.fr/actualites/acces-compassionnel-une-nouvelle-version-de-saturne-lapplication-de-demande-dautorisation-pour-les-professionnels-arrive-courant-avril
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-30 May 2024
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-27-30-may-2024
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2024
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-april-2024
List of medicines under additional monitoring
https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/pharmacovigilance-post-authorisation/medicines-under-additional-monitoring/list-medicines-under-additional-monitoring